SPARC.NS
SPARC.NS
INE232I01014
SUN PHARMA ADV.RES.CO.LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 391.483.000 717.660.000
45.5%
Cost of Revenue 513.879.000 1.099.596.000
53.3%
Gross Profit -122.396.000 -381.936.000
68.0%
-16.111.690.000 2.958.704.000
644.6%
Operating Income 15.989.294.000 -3.340.640.000
578.6%
Pretax Income 15.530.099.000 -3.427.812.000
553.1%
Net Income Common Stockholders 15.532.043.000 -3.425.094.000
553.5%
-- --
--
-- --
--
ende